21/08/2026
LONG-ACTING INJECTABLE PrEP (LEN)
One injection. Six months of HIV prevention protection.
What is LEN?
Lenacapavir (LEN) is a long-acting injectable medicine that helps prevent HIV infection. It is a form of Pre-Exposure Prophylaxis (PrEP) for people who are HIV-negative and at substantial risk of acquiring HIV.
One injection provides protection for six months.
Who can use LEN?
LEN is for people who are confirmed HIV-negative and assessed by a trained health worker to be at substantial risk of HIV infection.
This may include:
- People with an HIV-positive partner who is not virally suppressed or whose viral status is unknown.
- People with multiple s*xual partners.
- S*x workers.
- Men who have s*x with men.
- Transgender people at increased risk of HIV.
- People who inject drugs and share injecting equipment.
- Adolescent girls, young women and other young people at increased risk of HIV.
A health worker will assess whether LEN is right for you.
Before receiving LEN
You must:
- Have an HIV test and be confirmed HIV-negative.
- Have your HIV risk assessed by a trained health worker.
- Receive counselling on HIV prevention and follow-up.
Important to remember
- LEN does not cure or treat HIV.
- LEN does not prevent pregnancy or other s*xually transmitted infections (STIs).
Continue to:
- Use condoms correctly and consistently.
- Get HIV testing as advised.
- Practice safer s*x.
- Seek medical advice if you think you have been exposed to HIV.
Where is LEN available?
LEN is currently available at selected health facilities in Blantyre and Lilongwe.
Blantyre
- Gateway Clinic
- Naperi DIC
- Ndirande Health Centre
- Bangwe Health Centre
- Chileka Health Centre
- Mlambe Mission Hospital
- Chilomoni Health Centre
Lilongwe
- Area 25 Health Centre
- Kawale Health Centre
- A47 DIC
- Kabudula Community Hospital
- Likuni Mission Hospital
- Kamuzu Barracks
- Bwaila Hospital
Take action today
- Know your HIV status. Know your prevention choices.
If you are HIV-negative